Effect of Postoperative Family Nutrition Mode on Weight/BMI of Patients With Esophageal Cancer

Summary

This clinical trial is designed to be a multi-center prospective observational study which shall compare the effect of different postoperative home nutrition modes on recent nutritional index (weight/BMI) of patients with esophageal cancer and recent outcomes. Different postoperative home nutrition modes adopted in this study includes oral natural diet, oral nutrition supplement and tube feeding.

Conditions

• Esophageal Cancer

Interventions

DIETARY_SUPPLEMENT

Oral nutrition supplement

As for patients in oral nutrition supplement group, in addition to oral natural die, the participants shall receive oral enteral supplement providing 750-1500kcal/d.

DIETARY_SUPPLEMENT

Tube feeding nutrition supplement

As for patients in tube feeding group, in addition to oral natural die, the participants shall receive Tube feeding nutrition supplement providing 750-1500kcal/d.

Sponsors & Collaborators

• Sun Yat-sen University

  collaborator OTHER

• Zhejiang Cancer Hospital

  collaborator OTHER

• Shanghai Chest Hospital

  collaborator OTHER

• China-Japan Friendship Hospital

  collaborator OTHER

• Fudan University

  collaborator OTHER

• Shandong Provincial Hospital

  collaborator OTHER_GOV

• Hebei Medical University Fourth Hospital

  collaborator OTHER

• Anyang Tumor Hospital

  collaborator OTHER

• The First Affiliated Hospital of Anhui Medical University

  collaborator OTHER

• The First Affiliated Hospital of Bengbu Medical University

  collaborator OTHER

• Tongji Hospital

  collaborator OTHER

• Shanxi Province Cancer Hospital

  collaborator OTHER

• The Third Affiliated Hospital of Harbin Medical University

  collaborator OTHER

• Liaoning Cancer Hospital & Institute

  collaborator OTHER

• Wuhan General Hospital of Guangzhou Military Command

  collaborator OTHER

• Second Xiangya Hospital of Central South University

  collaborator OTHER

• The First Hospital of Jilin University

  collaborator OTHER

• Chinese PLA General Hospital

  collaborator OTHER

• Hunan Provincial People's Hospital

  collaborator OTHER

• Fujian Cancer Hospital

  collaborator OTHER_GOV

• Qilu Hospital of Shandong University

  collaborator OTHER

• Union hospital of Fujian Medical University

  collaborator OTHER

• Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

  collaborator OTHER

• Peking University Cancer Hospital & Institute

  lead OTHER

Principal Investigators

• Keneng Chen, M.D. · Peking University Cancer Hospital & Institute

Eligibility

Max Age

80 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2017-09-20

Primary Completion

2018-09-30

Completion

2018-09-30

Countries

• China

Study Locations